You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 3, March 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Brain White Matter Impairment in Congenital Adrenal Hyperplasia

Roberto Bergamaschi, MD; Chiara Livieri, MD; Carla Uggetti, MD; Elisa Candeloro, PhD; Maria Grazia Egitto, MD; Anna Pichiecchio, MD; Vittorio Cosi, MD; Stefano Bastianello, MD

Arch Neurol. 2006;63:413-416.

Background  Congenital adrenal hyperplasia (CAH) is an inherited recessive disorder of adrenal steroidogenesis. Past reports suggested that brain white matter could be involved in CAH.

Objective  To detect the presence, and possible changes over time, of brain white matter abnormalities in patients with CAH.

Design  Neurological examination and brain magnetic resonance imaging (MRI) that were repeated in 12 patients after a mean interval of 11 years.

Setting  Pavia, northern Italy.

Patients  Twenty-two patients with CAH.

Main Outcome Measures  Evaluation of clinical neurological findings and brain MRI T2-weighted images.

Results  Ten (45%) of 22 patients with CAH had white matter abnormalities (diffuse in 4 cases, focal in 3 cases, and both diffuse and focal in 3 cases) on MRI. The MRI findings never changed over repeated assessments.

Conclusions  Subclinical brain white matter involvement is frequent in CAH. This might be due to hormonal imbalance during brain development or corticosteroid treatments. Our study findings indicate that a relationship with demyelinating diseases can also be suggested. Diagnosis of CAH should be suspected in young subjects with brain MRI white matter abnormalities that are not otherwise explicable.


Author Affiliations: From the Multiple Sclerosis Center (Drs Bergamaschi and Candeloro), Service of Neuroradiology (Drs Uggetti, Egitto, Pichiecchio, and Bastianello), and Department of Neurology (Dr Cosi) of the Neurological Institute "C. Mondino," and from the Department of Applied Health Sciences (Dr Livieri), University of Pavia, Pavia, Italy.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.